Skip to main content
OpenTrials
Completed

NCT Number: NCT02244346

Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Study to evaluate the safety profile of Secotex® in the improvement of the symptoms of Benign Prostatic Hyperplasia in real clinical practice

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostatic Hyperplasia Genital Diseases Genital Diseases, Male Male Urogenital Diseases Prostatic Diseases Urogenital Diseases

Sex eligibility

Male

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients of any age with a diagnosis of symptomatic Benign Prostatic Hyperplasia (BPH)
  • Patients with symptoms, that according to physician require medical treatment to improve quality of life
  • Patients could be naive to treatment or could be on treatment with other drugs but have not responded adequately to treatment

Exclusion criteria

  • Patients with known hypersensitivity to Tamsulosin, or any other component of the product
  • Patients with a history of orthostatic hypotension or severe liver failure

Treatment and study plan

Secotex®

Drug

Primary outcomes

  1. Number of patients with adverse events

    Time frame: up to 6 months

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Secotex®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Important dates

Study start
2004
Primary completion
2004
First posted
Sep 19, 2014
Registry last updated
Sep 19, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.